Cathrin Brisken

Cathrin Brisken

Swiss Institute for Experimental Cancer Research, Ecole Polytechnique Fédérale de Lausanne

Affiliated withEcole Polytechnique Fédérale de Lausanne

Research Area

Biography

Cathrin Brisken has not added Biography.
If you are Cathrin Brisken and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
An <em>Ex vivo</em> Model to Study Hormone Action in the Human Breast
Publication title

Cited by 8

2015

Other Publications

Article
Year
Hormonal control of alveolar development and its implications for breast carcinogenesis.

Journal of mammary gland biology and neoplasia| PubMed ID: 12160085

2002
The signaling domain of the erythropoietin receptor rescues prolactin receptor-mutant mammary epithelium.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 12381781

2002
Prolactin signaling and Stat5: going their own separate ways?

Breast cancer research : BCR| PubMed ID: 12473164

2002
2002
Using gene expression arrays to elucidate transcriptional profiles underlying prolactin function.

Journal of mammary gland biology and neoplasia| PubMed ID: 14973373

2003
2004
2005
2005
Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 16452162

2006
Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 16501043

2006
Alveolar and lactogenic differentiation.

Journal of mammary gland biology and neoplasia| PubMed ID: 17111223

2006
Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 17369357

2007
2007
2007
2008
2008
2008
What signals operate in the mammary niche?

Breast disease| PubMed ID: 19029626

2008
2009
From normal cell types to malignant phenotypes.

Breast cancer research : BCR| PubMed ID: 19909495

2009
2010
Stem cells in chemical carcinogenesis.

Archives of toxicology| PubMed ID: 19941131

2010
Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 20133621

2010
2010
2010
2010
Hormone action in the mammary gland.

Cold Spring Harbor perspectives in biology| PubMed ID: 20739412

2010
High hopes for RANKL: will the mouse model live up to its promise?

Breast cancer research : BCR| PubMed ID: 21345281

2011
2011
Paracrine signaling by progesterone.

Molecular and cellular endocrinology| PubMed ID: 21945477

2012
ID4 regulates mammary gland development by suppressing p38MAPK activity.

Development (Cambridge, England)| PubMed ID: 22069192

2011
ER and PR signaling nodes during mammary gland development.

Breast cancer research : BCR| PubMed ID: 22809143

2012
miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 23233531

2013
Progesterone/RANKL is a major regulatory axis in the human breast.

Science translational medicine| PubMed ID: 23616122

2013
2013
2013
2013
A new Achilles Heel in breast cancer?

Oncotarget| PubMed ID: 23907591

2013
2014